GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CellCura ASA (FRA:C6L) » Definitions » EV-to-Revenue

CellCura ASA (FRA:C6L) EV-to-Revenue : 0.28 (As of Jun. 04, 2024)


View and export this data going back to . Start your Free Trial

What is CellCura ASA EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, CellCura ASA's enterprise value is €0.13 Mil. CellCura ASA's Revenue for the trailing twelve months (TTM) ended in Jun. 2014 was €0.46 Mil. Therefore, CellCura ASA's EV-to-Revenue for today is 0.28.

The historical rank and industry rank for CellCura ASA's EV-to-Revenue or its related term are showing as below:

FRA:C6L's EV-to-Revenue is not ranked *
in the Biotechnology industry.
Industry Median: 8.075
* Ranked among companies with meaningful EV-to-Revenue only.

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-06-04), CellCura ASA's stock price is €0.02. CellCura ASA's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2014 was €0.07. Therefore, CellCura ASA's PS Ratio for today is 0.27.


CellCura ASA EV-to-Revenue Historical Data

The historical data trend for CellCura ASA's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CellCura ASA EV-to-Revenue Chart

CellCura ASA Annual Data
Trend Dec08 Dec09 Dec10 Dec11 Dec12 Dec13
EV-to-Revenue
Get a 7-Day Free Trial - 25.02 68.41 14.19 10.96

CellCura ASA Quarterly Data
Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.12 7.79 10.96 8.25 10.11

Competitive Comparison of CellCura ASA's EV-to-Revenue

For the Biotechnology subindustry, CellCura ASA's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CellCura ASA's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CellCura ASA's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where CellCura ASA's EV-to-Revenue falls into.



CellCura ASA EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

CellCura ASA's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=0.130/0.46
=0.28

CellCura ASA's current Enterprise Value is €0.13 Mil.
CellCura ASA's Revenue for the trailing twelve months (TTM) ended in Jun. 2014 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.46 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CellCura ASA  (FRA:C6L) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

CellCura ASA's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=0.02/0.073
=0.27

CellCura ASA's share price for today is €0.02.
CellCura ASA's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2014 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.07.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CellCura ASA EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of CellCura ASA's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


CellCura ASA (FRA:C6L) Business Description

Traded in Other Exchanges
N/A
Address
Unionsgata 18, Skien, NOR, 3732
CellCura ASA is engaged in the development of novel equipment & products for use in Assisted Reproductive Technology & Stem Cell Research globally. The company also offers software solutions used in ART lab for securing the storage & management of data.

CellCura ASA (FRA:C6L) Headlines

No Headlines